How to Cite
Abstract
Objective: To see how much an intravenous iron treatment raises haemoglobin levels in children with iron deficiency anaemia who aren't improving with oral iron supplements.
Materials and Methods: A Quasi-experiment carried out at the POF Hospital in Wah Cantt's Department of Pediatrics. A total of 50 youngsters were tracked from October 2017 to March 2018. Venofer, an iron sucrose formulation, is administered in the prescribed dosage using a mathematical calculation. It was administered to patients as an indoor case over the course of an hour with a 1:1 dilution of normal saline, and Hb was repeated after a time of four weeks once again.
Results: According to our findings, the average age of the 50 children was 6.9 years, with a standard deviation of 2.98 years. 62 percent of the participants were men, while 38 percent were women. Hemoglobin levels were 6.12 g/dl at baseline, with a standard deviation of 1.15, and 8.20 g/dl after treatment completion, with a standard deviation of 2.02. Hemoglobin levels rose on average by 2.08 g/dl, with a standard deviation of 0.87.
Conclusion: We found a mean increase in haemoglobin of 2.08 g/dl with an SD of 0.87 in children with iron deficiency anaemia not responding to oral iron supplementation with intravenous iron treatment.
Keywords: mean rise in hemoglobin level, intravenous iron therapy, children, iron deficiency anemia, oral iron supplementations.